
Search ReportLinker
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Sam
+1 917 267 7886

... Or literature, among other things, to the fda as part of an ind. Some preclinical testing may continue even after the ind is submitted. An ind automatically becomes effective 30 days after receipt by the fda ...
... An option to assume primary responsibility for developing and promoting kb001-a for pa in cf or bronchiectasis patients after the completion of this phase 2 clinical trial. As part of sanofi S clinical ...
... Is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug cands for cancer. Curis is building ...
This report provides data on the therapeutic development for Mild Cognitive Impairment, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
House Dust Mite Allergy - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'House Dust Mite Allergy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...
- Product Pipeline Review - H2 2011? provides a detailed overview on the Lexicon Pharmaceuticals, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete ...
Reportlinker.com © Copyright 2013. All rights reserved.